Abstract
Malignant catatonia (MC) represents a life-threatening neuropsychiatric disorder that was widely reported both in the United States and abroad long before the introduction of antipsychotic drugs. Lack of recognition probably accounts for the relative paucity of contemporary North American reports on MC. Furthermore, MC is a syndrome rather than a specific disease entity that may occur as an outgrowth of diverse neuromedical illnesses as well as with the major psychoses. From this perspective, neuroleptic malignant syndrome (NMS), a potentially deadly complication of antipsychotic drug treatment, may be conceptualized as a drug-induced form of MC. The hypothesis that MC and NMS share a common pathophysiology, involving reduced dopamine functioning in the frontal-subcortical circuits, provides additional support for a view of NMS as a subtype of MC. Electroconvulsive therapy is the preferred treatment for MC stemming from a major psychotic disorder, and appears also effective in cases caused by neuromedical illnesses. Antipsychotic drugs should be withheld whenever MC is suspected.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychiatry Clini Neurosci. 1994;6:1–13.
Stauder KH. Die todliche Katatonie. Arch Psychiatr Nervenkr. 1934;102:614–34.
Calmeil LF. Dictionnaire de Medecine ou Repertoire General des Sciences. Medicales sous le Rapport Theorique et Practique. 2nd ed. Paris: Bechet; 1832.
Bell LV. On a form of disease resembling some advanced stages of mania and fever. Am J Insan. 1849;6:97–127.
Mann SC, Caroff SN, Bleier HR, et al. Lethal catatonia. Am J Psychiatry. 1986;143:1374–81.
Mann SC, Caroff SN, Bleier HR, et al. Electroconvulsive therapy of the lethal catatonia syndrome: case report and review. Convuls Ther. 1990;6:239–47.
Mann SC, Auriacombe M, Macfadden W, et al. Lethal catatonia: clinical aspects and therapeutic intervention; a review of the literature. Encéphale. 2001;27:213–6 (in French).
Mann SC, Caroff SN, Keck Jr PE, et al. The neuroleptic malignant syndrome and related conditions. 2nd ed. Arlington, VA: American Psychiatric Publishing Inc; 2003.
Mann SC, Caroff SN, Fricchione G, et al. Malignant catatonia. In: Caroff SN, Mann SC, Francis A, Fricchione G, editors. Catatonia: from psychopathology to neurobiology. Arlington, VA: American Psychiatric Publishing; 2004. p. 105–19.
Mann SC, Caroff SN, Campbell EC, et al. Malignant catatonia. In: Frucht SJ, Fahn S, editors. Movement disorder emergencies: diagnosis and treatment. Totowa, NJ: Humana Press, Inc.; 2005. p. 53–67.
Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry. 1980;41:79–83.
Arnold OH, Stepan H. Untersuchungen zur Frage der akuten todlichen Katotonie. Wien Z Nervenheilkd Grenzgeb. 1952;4:235–58.
Kraepelin E (1905) Lectures on Clinical Psychiatry (2nd ed.), Edited by Johnstone T. New York: William Wood
Ladame C. Psychose aigue idiopathique ou foudroyante. Schweizer Archiv fur Neurologic und Psychiatrie. 1919;5:3–28.
Levine T, Petrides G, Weiner J, et al. Intractable delirium associated with ziconotide successfully treated with electroconvulsive therapy. Psychosomatics. 2002;43:10–7.
Slooter JC, Braun KPJ, Balk FJE, et al. Electroconvulsive therapy for catatonia in childhood. Pediatr Neurol. 2005;32:190–2.
Lee A, Glick DB, Dinwiddie SH. Electroconvulsive therapy in a pediatric patient with malignant catatonia paraneoplastic limbic encephalitis. J ECT. 2006;22:267–70.
Oyama Y, Suzuki K, Honda T, et al. Respiratory distress due to elderly catatonia resolved with ECT.Clinical. Psychiatry. 2006;48:51–6.
Ter Haar IM, Rutgers RJ, Egbers PH. A young woman with a labile mood, hyperactivity, hyperthermia, and exhaustion: symptoms of lethal catatonia. Ned Tijdschr Geneeskd. 2006;150:1753–5 (in Dutch).
Dale RC, Webster W, Gill D. Contemporary encephalitis lethargica presenting with agitated catatonia, stereotypy, and dystonia-parkinsonism. Mov Disord. 2007;15:2281–4.
Ono Y, Manabe Y, Hanakawa Y, et al. Steroid responsive encephalitis lethargica with malignant catatonia. Intern Med. 2007;46:307–10.
Kaestner F, Mostert C, Behnken I, et al. Therapeutic strategies for catatonia in paraneoplastic encephalitis. World J Biol Psychiatry. 2008;9:236–40.
Dhossche DM, Shashidhar SM, Kumar T, et al. Electroconvulsive therapy for malignant catatonia in adolescence. South Med J. 2009;102:1170–2.
Nisijima K. Malignant catatonia accompanied by high urinary catecholamine levels mimicking the presentation of pheochromocytoma. Psychiatry Clin Neurosci. 2009;63:428–9.
Detweiler MB, Mehra A, Rowell T, et al. Delirious mania and malignant catatonia; a report of 3 cases and review. Psychitr Q. 2009;80:23–40.
Shafti SS, Nicknam Z, Fallah P, et al. Early psychiatric manifestations in a patient with primary progressive multiple sclerosis. Arch Iran Med. 2009;12:595–8.
Brown M, Freeman F. Clonazepam withdrawal-induced catatonia. Psychosomatics. 2009;50:289–92.
Suzuki H, Fukushima T, Makino K, et al. Patient with encephalitis lethargica presenting with olanzapine-responsive malignant catatonia. Rinsho Shinkeigaku. 2010;50:329–31 (in Japanese).
Moltke K, Lublin H. Malignant catatonia, a neuropsychiatric syndrome. Ugeskr Laeger. 2010;172:1305–6 (in Dutch).
Wachtel LE, Crawford TO, Dhossche DM, et al. Electroconvulsive therapy for pediatric malignant catatonia with cerebellar dysgenesis. Pediatr Neurol. 2010;43:427–30.
Rasmussen KG, Hart DA, Lineberry TW. ECT in patients with psychopathology related to acute neurologic illness. Psychosomatics. 2010;49:67–72.
Tuerlings JH, van Waarde JA, Verwey B. A retrospective study of 34 catatonic patients: analysis of clinical care and treatment. Gen Hosp Psychiatry. 2010;32:631–5.
Koziel-Schminda E. “Ostra Smierteina Katatonia” Typu Staudera O Przebiegu Letalny(Analiza Materialow Kliniczynch I Sekcyjnch Szpitala W Kochborowie Z Lat (1950–1970). Psychiatr Pol. 1973;7:563–7.
Hafner H, Kasper S. Akute lebensbedrohliche Katatonie: Epidemiologische und Klinische Befunde. Nervenzart. 1982;53:385–94.
Singerman S, Raheja R. Malignant catatonia-a continuing reality. Ann Clin Psychiatry. 1994;6:259–66.
Wilson LG. Viral encephalopathy mimicking functional psychosis. Am J Psychiatry. 1976;133:165–70.
Fricchione G, Bush G, Fozdar M, et al. Recognition and treatment of the catatonic syndrome. J Intensive Care Med. 1997;12:135–47.
Fricchione G, Mann SC, Caroff SN. Catatonia, lethal catatonia, and neuroleptic malignant syndrome. Psychiatr Ann. 2000;3:347–55.
Mann SC, Caroff SN, Fricchione G, et al. Central dopamine hypoactivity and the pathogenesis of neuroleptic malignant syndrome. Psychiatr Ann. 2000;30:363–74.
Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci. 1986;9:357–81.
Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res. 1990;85:119–46.
Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50:873–80.
Deutch AY, Bourdelais AJ, Zahm DS. The nucleus accumbens core and shell: accumbal compartments and their functional attributes. In: Kalivas PW, Barnes CD, editors. Limbic Motor Circuits and neuropsychiatry. Boca Raton FL: CRC Press; 1993. p. 163–75.
Taylor MA. Catatonia: a review of a behavioral neurologic syndrome. Neuropsychiatry Neuropsychol Behav Neurol. 1990;3:48–72.
Thierry AM, Tassin JP, Blanc G, et al. Selective activation of the mesocortical dopamine system by stress. Nature. 1976;263:242–4.
Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660–9.
Pycock CL, Kerwin RW, Carter CJ. Effects of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 1980;286:74–6.
Sedivic V. Psychoses endangering life. Cesk Psychiatr. 1981;77:38–41 (In Czech).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mann, S.C., Caroff, S.N., Bleier, H.R., Campbell, E.C. (2013). Malignant Catatonia. In: Frucht, S. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-835-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-60761-835-5_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-834-8
Online ISBN: 978-1-60761-835-5
eBook Packages: MedicineMedicine (R0)